62 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
inflammatory. The SCD selectively targets the most highly activated proinflammatory neutrophils and monocytes. These cells are then returned back
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
monocytes to a reparative state and
promote activated neutrophils to be less inflammatory. The SCD selectively targets the most highly activated
8-K/A
EX-99.1
ICU
SeaStar Medical Holding Corp
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
5:23pm
to be less inflammatory. The SCD selectively targets the most highly activated proinflammatory neutrophils and monocytes. These cells are then returned
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
27 Mar 24
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
8:32am
to be less inflammatory. The SCD selectively targets the most highly activated proinflammatory neutrophils and monocytes. These cells are then returned
424B3
f4ewkwg7
5 Mar 24
Prospectus supplement
5:08pm
424B3
bz085v
5 Mar 24
Prospectus supplement
4:59pm
424B3
yq8lz5 453s
5 Mar 24
Prospectus supplement
4:56pm
8-K
EX-99.1
kpsvpu s86rcet9
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
8-K
EX-99.1
tq3kl9 oo9f1v
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
EX-99.1
mljel
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
424B3
3hq phgcgis8q
6 Oct 23
Prospectus supplement
1:08pm
424B3
viyjgdrwt9vjgi
6 Oct 23
Prospectus supplement
1:06pm
424B3
vyixt6gcw46j 43
6 Oct 23
Prospectus supplement
1:04pm
424B3
m90ljq
6 Oct 23
Prospectus supplement
12:59pm
8-K
EX-99.1
mzbv4 nx81rnge3tu779
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
EX-99.1
rwrstlh9fc9
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
424B7
xzrz 4m8gqii
10 Aug 23
Prospectus with selling stockholder info
4:00pm